ESTRO 2025 - Abstract Book

S1667

Clinical - Sarcoma & skin cancer & malignant melanoma

ESTRO 2025

Table 1. Multivariable analysis

CI; Confidence interval, cm; centimeter, HR; Hazard ratio, SCC; Squamous cell carcinom

Conclusion: Patients who developed regional recurrence had worse survival. High-risk patients might benefit from regional management, such as sentinel lymph node biopsy or elective nodal irradiation.

Keywords: Non-melanoma skin cancer, Regional recurrence

1045

Mini-Oral Prognostic subgroups for disease-free survival in cutaneous squamous cell carcinoma of the head and neck: A secondary analysis of the TROG 05.01 Trial Emma Connolly 1 , Mathias Bressel 2,3 , Howard Yu-hao Liu 4,5 , Danny Rischin 3,6 , Sandro Porceddu 1,3,4 1 Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. 2 Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Australia. 3 Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. 4 Faculty of Medicine, University of Brisbane, Brisbane, Australia. 5 Department of Radiation Oncology, Princess Alexandra Hospital, Woolloongabba, Australia. 6 Department of Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia